MDXH NASDAQ
MDxHealth S.A.
1W: +1.0%
1M: -19.6%
3M: +18.2%
YTD: -83.3%
1Y: -87.8%
3Y: -79.6%
$0.57
-0.01 (-0.90%)
Weekly Expected Move ±9.5%
$0
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Revenue Segmentation
By Product / Service
By Geography
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$108M
+19.8% ▲
5Y CAGR: +42.3%
Gross Profit
$64M
+16.9% ▲
5Y CAGR: +51.6%
Operating Income
-$15M
+37.7% ▲
Net Income
-$34M
+12.0% ▲
EPS (Diluted)
$-0.67
+42.2% ▲
EBITDA
-$6M
+71.9% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $22M | $37M | $70M | $90M | $108M |
| YoY Growth | +20.5% | +66.6% | +89.4% | +28.3% | +19.8% |
| Cost of Revenue | $12M | $18M | $26M | $35M | $43M |
| Gross Profit | $11M | $19M | $44M | $55M | $64M |
| Gross Margin | 47.5% | 51.9% | 62.6% | 61.2% | 59.7% |
| R&D Expenses | $6M | $8M | $6M | $11M | $10M |
| SG&A Expenses | $30M | $50M | $60M | $61M | $69M |
| Operating Expenses | $37M | $57M | $71M | $80M | $80M |
| Operating Income | -$27M | -$38M | -$27M | -$25M | -$15M |
| Operating Margin | -120.7% | -102.3% | -38.9% | -27.5% | -14.3% |
| Interest Expense | $2M | $3M | $6M | $8M | $21M |
| Income Before Tax | -$29M | -$44M | -$43M | -$38M | -$35M |
| Tax Expense | $0 | $0 | $1K | $382K | -$2M |
| Net Income | -$29M | -$44M | -$43M | -$38M | -$34M |
| Net Margin | -130.4% | -118.9% | -61.4% | -42.3% | -31.1% |
| EPS (Diluted) | $-2.38 | $-2.78 | $-1.66 | $-1.16 | $-0.67 |
| EBITDA | -$24M | -$36M | -$30M | -$22M | -$6M |
| Shares Outstanding | 12M | 16M | 26M | 49M | 50M |